| [1] |
林大卫, 周达新. 卵圆孔未闭研究现状与进展[J/OL]. 中华心脏与心律电子杂志,2024,12(2):65-71.
|
| [2] |
Calvert PA, Rana BS, Kydd AC, et al. Patent foramen ovale: anatomy, outcomes, and closure[J]. Nat Rev Cardiol, 2011, 8(3):148-160.
|
| [3] |
Kerut EK, Norfleet WT, Plotnick GD, et al. Patent foramen ovale: a review of associated conditions and the impact of physiological size[J]. J Am Coll Cardiol, 2001, 38(3):613-623.
|
| [4] |
Homma S, Messé SR, Rundek T, et al. Patent foramen ovale[J]. Nat Rev Dis Primers, 2016, 2:15086.
|
| [5] |
中国医师协会心血管内科医师分会. 卵圆孔未闭处理策略中国专家建议[J]. 心脏杂志, 2015, 27(4):373-379.
|
| [6] |
中国人体健康科技促进会结构性心脏病专委会, 中国医师协会神经内科分会, 张玉顺, 等. 卵圆孔未闭相关非卒中性疾病防治中国专家共识[J]. 心脏杂志, 2024, 36(2):125-134.
|
| [7] |
中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 卵圆孔未闭规范化诊疗中国专家共识[J]. 中华心血管病杂志, 2024, 52(4):369-383.
|
| [8] |
Ferrari MD, Goadsby PJ, Burstein R, et al. Migraine[J]. Nat Rev Dis Primers, 2022, 8(1):2.
|
| [9] |
Iwasaki A, Suzuki K, Takekawa H, et al. Prevalence of right to left shunts in japanese patients with migraine: a single-center study[J]. Intern Med, 2017, 56(12):1491- 1495.
|
| [10] |
中国医师协会神经内科医师分会, 中国研究型医院学会头痛与感觉障碍专业委员会. 中国偏头痛诊治指南(2022版)[J]. 中国疼痛医学杂志, 2022, 28(12):881-898.
|
| [11] |
Del Sette M, Angeli S, Leandri M, et al. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study[J]. Cerebrovasc Dis, 1998, 8(6):327-330.
|
| [12] |
Anzola GP, Magoni M, Guindani M, et al. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study[J]. Neurology, 1999, 52(8):1622-1625.
|
| [13] |
Tang Y, Peng A, Peng B, et al. Association between patent foramen ovale and migraine without aura: a community-based cross-sectional study in China[J]. BMJ Open, 2022, 12(3):e056937.
|
| [14] |
Schwerzmann M, Nedeltchev K, Lagger F, et al. Prevalence and size of directly detected patent foramen ovale in migraine with aura[J]. Neurology, 2005, 65(9):1415-1418.
|
| [15] |
Rundek T, Elkind MSV, Di Tullio MR, et al. Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan study (NOMAS)[J]. Circulation, 2008, 118(14):1419-1424.
|
| [16] |
Ozge A, Ozge C, Oztürk C, et al. The relationship between migraine and atopic disorders-the contribution of pulmonary function tests and immunological screening[J]. Cephalalgia, 2006, 26(2):172-179.
|
| [17] |
Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association[J]. Stroke, 2021, 52(7):e364-e467.
|
| [18] |
Yan C, Li H, Wang C, et al. Frequency and size of in situ thrombus within patent foramen ovale[J]. Stroke, 2023, 54(5):1205-1213.
|
| [19] |
Guo ZN, Xing Y, Liu J, et al. Compromised dynamic cerebral autoregulation in patients with a right-to-left shunt: a potential mechanism of migraine and cryptogenic stroke[J]. PLoS One, 2014, 9(8):e104849.
|
| [20] |
Szczygioł D, Motta E, Gołba A, et al. Frequency of the C677T variant of the methylenetetrahydrofolate reductase (MTHFR) gene in patients with migraine with or without aura - a preliminary report[J]. Neurol Neurochir Pol, 2012, 46(5):443-449.
|
| [21] |
Trabattoni D, Brambilla M, Canzano P, et al. Migraine in patients undergoing PFO closure: characterization of a platelet-associated pathophysiological mechanism: the LEARNER study[J]. JACC Basic Transl Sci, 2022, 7(6):525-540.
|
| [22] |
Carroll JD. Migraine intervention with STARFlex technology trial: a controversial trial of migraine and patent foramen ovale closure[J]. Circulation, 2008, 117(11):1358-1360.
|
| [23] |
Gilbert GJ. Different degrees of right-to-left shunting predict migraine and stroke: data from 420 patients[J]. Neurology, 2006, 67(5):919-920.
|
| [24] |
Wilmshurst PT, Nightingale S, Walsh KP, et al. Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons[J]. Lancet, 2000, 356(9242):1648-1651.
|
| [25] |
Dowson A, Mullen MJ, Peatfield R, et al. Migraine intervention with STARFlex technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache[J]. Circulation, 2008, 117(11):1397-1404.
|
| [26] |
Tobis JM, Charles A, Silberstein SD, et al. Percutaneous closure of patent foramen ovale in patients with migraine: the PREMIUM trial[J]. J Am Coll Cardiol, 2017, 70(22):2766-2774.
|
| [27] |
Mattle HP, Evers S, Hildick-Smith D, et al. Percutaneous closure of patent foramen ovale in migraine with aura, a randomized controlled trial[J]. Eur Heart J, 2016, 37(26):2029-2036.
|
| [28] |
Mas JL, Guillon B, Charles-Nelson A, et al. Patent foramen ovale closure in stroke patients with migraine in the CLOSE trial. The CLOSE-MIG study[J]. Eur J Neurol, 2021, 28(8):2700-2707.
|
| [29] |
He Q, Zhang Y, Wang F, et al. Impact of right-to-left shunt and transcatheter closure on the clinical features of migraine[J]. Int J Neurosci, 2020, 130(3):270-275.
|
| [30] |
Luermans JG, Post MC, Temmerman F, et al. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine: a prospective observational study[J]. Acta Cardiol, 2008, 63(5):571-577.
|
| [31] |
Reisman M, Christofferson RD, Jesurum J, et al. Migraine headache relief after transcatheter closure of patent foramen ovale[J]. J Am Coll Cardiol, 2005, 45(4):493-495.
|
| [32] |
Xing YQ, Guo YZ, Gao YS, et al. Effectiveness and safety of transcatheter patent foramen ovale closure for migraine (EASTFORM) trial[J]. Sci Rep, 2016, 6:39081.
|
| [33] |
季春影, 黄朝旭, 李晶, 等. 偏头痛患者行卵圆孔未闭封堵术后1年残余分流与疗效分析[J]. 中国循环杂志, 2024, 39(9):883-888.
|
| [34] |
Silalahi T, Hariyanto TI. Efficacy and safety of patent foramen ovale closure for mitigating migraine: a systematic review and meta-analysis of randomized trials and observational studies[J]. Ther Adv Neurol Disord, 2024, 17:17562864241271033.
|
| [35] |
Zhao E, Xie H, Zhang Y. A Nomogram for the prediction of cessation of migraine among patients with patent foramen ovale after percutaneous closure[J]. Front Neurol, 2020, 11:593074.
|
| [36] |
Corrigendum to: European position paper on the management of patients with patent foramen ovale. Part II-Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions[J]. Eur Heart J, 2021, 42(21):2102.
|
| [37] |
王华, 陈科宇, 秦永文, 等. 新型卵圆孔未闭封堵器的研制及临床应用进展[J]. 心血管病学进展, 2023, 44(9):781-785.
|
| [38] |
Gaspardone A, De Marco F, Sgueglia GA, et al. Novel percutaneous suture-mediated patent foramen ovale closure technique: early results of the NobleStitch EL Italian Registry[J]. EuroIntervention, 2018, 14(3):e272-e279.
|
| [39] |
Mitchell SJ, Bennett MH, Moon RE. Decompression sickness and arterial gas embolism[J]. N Engl J Med, 2022, 386(13):1254-1264.
|
| [40] |
Nagraj S, Palaiodimos L. Patent foramen ovale and decompression illness: the present and future[J]. Cardiol Clin, 2024, 42(4):525-536.
|
| [41] |
Vann RD, Butler FK, Mitchell SJ, et al. Decompression illness[J]. Lancet, 2011, 377(9760):153-164.
|
| [42] |
Apostolos A, Drakopoulou M, Trantalis G, et al. The management of patent foramen ovale in divers: where do we stand?[J]. Ther Adv Neurol Disord, 2022, 15:17562864221103459.
|
| [43] |
Palaiodimos L, Mahato P, Gershon A, et al. Chapter 13 - Less recognized conditions associated with PFO: decompression illness, carcinoid heart disease, coronary spasm[M]. Patent foramen ovale closure for stroke, myocardial infarction, peripheral embolism, migraine, and hypoxemia, 2020:155-167.
|
| [44] |
Honěk J, Šrámek M, Šefc L, et al. High-grade patent foramen ovale is a risk factor of unprovoked decompression sickness in recreational divers[J]. J Cardiol, 2019, 74(6):519-523.
|
| [45] |
Lee HJ, Lim DS, Lee J, et al. Decompression illness in divers with or without patent foramen ovale : a cohort study[J]. Ann Intern Med, 2023, 176(7):934-939.
|
| [46] |
Honěk J, Šrámek M, Honěk T, et al. Patent foramen ovale closure is effective in divers: long-term results from the DIVE-PFO registry[J]. J Am Coll Cardiol, 2020, 76(9):1149-1150.
|
| [47] |
Honěk J, Srámek M, Sefc L, et al. Effect of catheter-based patent foramen ovale closure on the occurrence of arterial bubbles in scuba divers[J]. JACC Cardiovasc Interv, 2014, 7(4):403-408.
|
| [48] |
Honěk J, Šrámek M, Honěk T, et al. Screening and risk stratification strategy reduced decompression sickness occurrence in divers with patent foramen ovale[J]. JACC Cardiovasc Imaging, 2022, 15(2):181-189.
|
| [49] |
Agrawal A, Palkar A, Talwar A. The multiple dimensions of Platypnea-Orthodeoxia syndrome: a review[J]. Respir Med, 2017, 129:31-38.
|
| [50] |
Akin E, Krüger U, Braun P, et al. The platypnea-orthodeoxia syndrome[J]. Eur Rev Med Pharmacol Sci, 2014, 18(18):2599-2604.
|
| [51] |
Knapper JT, Schultz J, Das G, et al. Cardiac platypnea-orthodeoxia syndrome: an often unrecognized malady[J]. Clin Cardiol, 2014, 37(10):645-649.
|
| [52] |
Salas-Pacheco JL. [Mechanisms of platypnea-orthodeoxia syndrome][J]. Arch Cardiol Mex, 2022, 92(2):274-282.
|
| [53] |
Soares PR, Melo N, Ferrao D, et al. Platypnea-orthodeoxia syndrome: a rare cause of positional respiratory failure[J]. Cureus, 2022, 14(12):e32538.
|
| [54] |
Agdamag AC, Gomez JM, Collado FM, et al. Patent foramen ovale and ascending aortic aneurysm causing the platypnea-orthodeoxia syndrome[J]. Proc (Bayl Univ Med Cent), 2019, 32(2):242-244.
|
| [55] |
Guimarães J, Costa P, Ferreira J. Platypnea-Orthodeoxia: a case of PFO with aortic compression[J]. Neth Heart J, 2025.
|
| [56] |
Oliveira J, Arandjelovic M, Pintor I, et al. Platypnea-Orthodeoxia syndrome: manifestation of a patent foramen ovale[J]. Cureus, 2024, 16(12):e75970.
|
| [57] |
Jiménez-Segovia F, Luis-García S, González-San Narciso C, et al. Platypnea-Orthodeoxia syndrome and COVID-19 successfully treated with percutaneous patent foramen ovale closure: a report of two cases and literature review[J]. Cureus, 2024, 16(3):e56655.
|
| [58] |
Alotaibi FF, Alotaibi RM, Almalki ME, et al. Patent foramen ovale-induced Platypnea-Orthodeoxia syndrome: a case report and literature review[J]. Cureus, 2022, 14(12):e32203.
|
| [59] |
Othman F, Bailey B, Collins N, et al. Platypnea-Orthodeoxia syndrome in the setting of patent foramen ovale without pulmonary hypertension or major lung disease[J]. J Am Heart Assoc, 2022, 11(15):e024609.
|
| [60] |
Shah AH, Osten M, Leventhal A, et al. Percutaneous intervention to treat Platypnea-Orthodeoxia syndrome: the Toronto experience[J]. JACC Cardiovasc Interv, 2016, 9(18):1928-1938.
|
| [61] |
Kleber FX, Hauschild T, Schulz A, et al. Epidemiology of myocardial infarction caused by presumed paradoxical embolism via a patent foramen ovale[J]. Circ J, 2017, 81(10):1484-1489.
|
| [62] |
Stefan G, Badea AM, Spataru D, et al. Paradoxical renal embolization via patent foramen ovale: a case of complicated pulmonary embolism and renal infarction mitigated by accessory renal arteries (nephrology images)[J]. J Nephrol, 2023, 36(9):2645-2647.
|
| [63] |
Jolobe O. Paradoxical embolism as a cause of renal and/or splenic infarction[J]. QJM, 2020, 113(6):442-443.
|
| [64] |
Liu XQ, Wang XY, Xie H, et al. The discovery of in situ thrombus attached to the patent foramen ovale channel in myocardial infarction with normal coronary arteries[J]. Heliyon, 2024, 10(15):e35220.
|
| [65] |
Ravi D, Parikh RV, Aboulhosn J, et al. A new syndrome of patent foramen ovale inducing vasospastic angina and migraine[J]. JACC Case Rep, 2023, 28:102132.
|
| [66] |
心血管健康联盟. 结构性心脏病2024年度报告｜先心篇:前沿研究、最新指南指导先心病介入治疗规范化发展[EB/OL]. (2025-01-20) [2025-03-15].
URL
|
| [67] |
Goldsweig AM, Deng Y, Yao X, et al. Approval, evidence, and "off-label" device utilization: the patent foramen ovale closure story[J]. Circ Cardiovasc Qual Outcomes, 2024, 17(1):e010200.
|